These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 32435388)

  • 1. Drug Synergism: Studies of Combination of RK-52 and Curcumin against Rhodesain of
    Ettari R; Previti S; Di Chio C; Maiorana S; Allegra A; Schirmeister T; Zappalà M
    ACS Med Chem Lett; 2020 May; 11(5):806-810. PubMed ID: 32435388
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug Combination Studies of the Dipeptide Nitrile CD24 with Curcumin: A New Strategy to Synergistically Inhibit Rhodesain of
    Di Chio C; Previti S; De Luca F; Bogacz M; Zimmer C; Wagner A; Schirmeister T; Zappalà M; Ettari R
    Int J Mol Sci; 2022 Nov; 23(22):. PubMed ID: 36430948
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dipeptide Nitrile CD34 with Curcumin: A New Improved Combination Strategy to Synergistically Inhibit Rhodesain of
    Di Chio C; Previti S; Totaro N; De Luca F; Allegra A; Schirmeister T; Zappalà M; Ettari R
    Int J Mol Sci; 2023 May; 24(10):. PubMed ID: 37239824
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug combination studies of PS-1 and quercetin against rhodesain of
    Di Chio C; Previti S; De Luca F; Allegra A; Zappalà M; Ettari R
    Nat Prod Res; 2022 Aug; 36(16):4282-4286. PubMed ID: 34533390
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug combination studies of curcumin and genistein against rhodesain of
    Ettari R; Previti S; Maiorana S; Allegra A; Schirmeister T; Grasso S; Zappalà M
    Nat Prod Res; 2019 Dec; 33(24):3577-3581. PubMed ID: 29897253
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Active site mapping, biochemical properties and subcellular localization of rhodesain, the major cysteine protease of Trypanosoma brucei rhodesiense.
    Caffrey CR; Hansell E; Lucas KD; Brinen LS; Alvarez Hernandez A; Cheng J; Gwaltney SL; Roush WR; Stierhof YD; Bogyo M; Steverding D; McKerrow JH
    Mol Biochem Parasitol; 2001 Nov; 118(1):61-73. PubMed ID: 11704274
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optimization Strategy of Novel Peptide-Based Michael Acceptors for the Treatment of Human African Trypanosomiasis.
    Ettari R; Previti S; Maiorana S; Amendola G; Wagner A; Cosconati S; Schirmeister T; Hellmich UA; Zappalà M
    J Med Chem; 2019 Dec; 62(23):10617-10629. PubMed ID: 31714776
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure, interdomain dynamics, and pH-dependent autoactivation of pro-rhodesain, the main lysosomal cysteine protease from African trypanosomes.
    Johé P; Jaenicke E; Neuweiler H; Schirmeister T; Kersten C; Hellmich UA
    J Biol Chem; 2021; 296():100565. PubMed ID: 33745969
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Should the enzyme name 'rhodesain' be discontinued?
    Steverding D; Caffrey CR
    Mol Biochem Parasitol; 2021 Sep; 245():111395. PubMed ID: 34246720
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New peptidomimetic rhodesain inhibitors with improved selectivity towards human cathepsins.
    Jung S; Fuchs N; Grathwol C; Hellmich UA; Wagner A; Diehl E; Willmes T; Sotriffer C; Schirmeister T
    Eur J Med Chem; 2022 Aug; 238():114460. PubMed ID: 35597010
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comments on "Drug combination studies of curcumin and genistein against rhodesain of
    Steverding D
    Nat Prod Res; 2020 Mar; 34(6):751-753. PubMed ID: 30251878
    [No Abstract]   [Full Text] [Related]  

  • 12. Development of Novel Benzodiazepine-Based Peptidomimetics as Inhibitors of Rhodesain from Trypanosoma brucei rhodesiense.
    Di Chio C; Previti S; Amendola G; Cosconati S; Schirmeister T; Zappalà M; Ettari R
    ChemMedChem; 2020 Jun; 15(11):995-1001. PubMed ID: 32329206
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of Reduced Peptide Bond Pseudopeptide Michael Acceptors for the Treatment of Human African Trypanosomiasis.
    Previti S; Ettari R; Di Chio C; Ravichandran R; Bogacz M; Hellmich UA; Schirmeister T; Cosconati S; Zappalà M
    Molecules; 2022 Jun; 27(12):. PubMed ID: 35744891
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Inhibition of Cysteine Proteases Rhodesain and TbCatB: A Valuable Approach to Treat Human African Trypanosomiasis.
    Ettari R; Previti S; Tamborini L; Cullia G; Grasso S; Zappalà M
    Mini Rev Med Chem; 2016; 16(17):1374-1391. PubMed ID: 27156518
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Two Tags in One Probe: Combining Fluorescence- and Biotin-based Detection of the Trypanosomal Cysteine Protease Rhodesain.
    Lemke C; Jílková A; Ferber D; Braune A; On A; Johe P; Zíková A; Schirmeister T; Mareš M; Horn M; Gütschow M
    Chemistry; 2022 Nov; 28(62):e202201636. PubMed ID: 35852812
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of Novel Peptide-Based Michael Acceptors Targeting Rhodesain and Falcipain-2 for the Treatment of Neglected Tropical Diseases (NTDs).
    Previti S; Ettari R; Cosconati S; Amendola G; Chouchene K; Wagner A; Hellmich UA; Ulrich K; Krauth-Siegel RL; Wich PR; Schmid I; Schirmeister T; Gut J; Rosenthal PJ; Grasso S; Zappalà M
    J Med Chem; 2017 Aug; 60(16):6911-6923. PubMed ID: 28763614
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discovery of novel natural products as rhodesain inhibitors for human African trypanosomiasis using in silico techniques.
    Elrufaie HA; Mohamed LM; Hamd AY; Bala NA; Elbadawi FA; Ghaboosh H; Alzain AA
    J Biomol Struct Dyn; 2023; 41(12):5672-5684. PubMed ID: 35751127
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of rhodesain as a novel therapeutic modality for human African trypanosomiasis.
    Ettari R; Tamborini L; Angelo IC; Micale N; Pinto A; De Micheli C; Conti P
    J Med Chem; 2013 Jul; 56(14):5637-58. PubMed ID: 23611656
    [TBL] [Abstract][Full Text] [Related]  

  • 19. On the Reversible and Irreversible Inhibition of Rhodesain by Curcumin.
    Steverding D
    Molecules; 2019 Dec; 25(1):. PubMed ID: 31905815
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of Urea-Bond-Containing Michael Acceptors as Antitrypanosomal Agents Targeting Rhodesain.
    Previti S; Ettari R; Calcaterra E; Di Chio C; Ravichandran R; Zimmer C; Hammerschmidt S; Wagner A; Bogacz M; Cosconati S; Schirmeister T; Zappalà M
    ACS Med Chem Lett; 2022 Jul; 13(7):1083-1090. PubMed ID: 35859868
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.